Can low ferritin and below-optimal hemoglobin reduce thyroid function and oxygen delivery?

Low ferritin, alongside below-optimal hemoglobin and red blood cell (RBC) counts, compromises both cellular metabolism and endocrine function by restricting systemic iron stores and oxygen transport.

Thyroid synthesis and metabolic pathways

• Thyroid peroxidase (TPO) inhibition: TPO is a heme-dependent, iron-requiring enzyme that catalyzes the essential oxidation, iodination, and coupling steps required to synthesize thyroxine ($T_4$) and triiodothyronine ($T_3$). Low ferritin depletes the intracellular iron pools needed for heme biosynthesis, directly reducing TPO activity and slowing thyroid hormone production.
• Impaired peripheral conversion: Depleted iron stores secondarily suppress hepatic type 1 deiodinase (D1) activity, which is responsible for converting inactive $T_4$ to active $T_3$ in peripheral tissues. A reduction in D1 activity shifts thyroid metabolism toward deactivating pathways, potentially increasing reverse $T_3$ ($rT_3$) and leading to functional tissue-level hypothyroidism.

Oxygen delivery and tissue hypoxia

• Reduced carrying capacity: Because 97% to 98% of blood oxygen is bound to hemoglobin—with each gram of hemoglobin binding approximately 1.34 mL of oxygen—below-optimal hemoglobin and RBC counts directly lower arterial oxygen content ($CaO_2$).
• Systemic delivery failure: This decline in $CaO_2$ proportionally reduces systemic oxygen delivery ($DO_2$). When compensatory extraction thresholds are surpassed, this restriction limits oxygen transport to skeletal muscles and vital organs, triggering tissue hypoxia and impairing overall aerobic capacity.

Bottom line

• Concurrently low ferritin, hemoglobin, and RBC counts impair thyroid function by inhibiting heme-dependent thyroid peroxidase and peripheral T4-to-T3 conversion, while simultaneously reducing systemic oxygen delivery to tissues, resulting in a combined state of metabolic and aerobic exhaustion.